Keene & Associates’s Exelon EXC Stock Holding History

Keene & Associates’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-84,692	Closed	-$3.49M	–	82
2021 Q4	$3.49M	Buy	+84,692	New	+$3.19M	3.01%	7

Other funds holding EXC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Keene & Associates's EXC Position: Q1 2022 in Review

Keene & Associates sold out of Exelon (EXC) in Q1 2022, closing a stake of 84,692 shares — an estimated $3.49M sold.

Keene & Associates first reported a position in EXC in Q4 2021 and held it in 1 quarter. The position peaked at $3.49M in Q4 2021. 1,025 funds tracked by Wall St. Rank hold EXC as of Q1 2022.

Keene & Associates reported no remaining Exelon position as of Q1 2022 after selling out during the quarter.
Keene & Associates sold 84,692 Exelon shares in Q1 2022, an estimated $3.49M.
Keene & Associates first reported a position in Exelon in Q4 2021 and held it in 1 quarter.
Keene & Associates's Exelon position peaked at $3.49M in Q4 2021.
1,025 funds tracked by Wall St. Rank held Exelon as of Q1 2022.

Based on Keene & Associates's 13F filing for Q1 2022, filed 12 Apr 2022.